GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Distribution » Sinopharm Group Co Ltd (FRA:X2S) » Definitions » Dividend-Payout-to-FFO

Sinopharm Group Co (FRA:X2S) Dividend-Payout-to-FFO


View and export this data going back to 2009. Start your Free Trial

What is Sinopharm Group Co Dividend-Payout-to-FFO?

Dividend-Payout-to-FFO only applies to REITs.


Sinopharm Group Co Business Description

Address
No. 385, East Longhua Road, Sinopharm Group Building, Huangpu District, Shanghai, CHN, 200023
Founded in 2003, Sinopharm is the largest wholesaler and retailer of drugs and medical devices in China and listed on the Hong Kong Stock Exchange in 2009. It is a core subsidiary of China National Pharmaceutical Group. Sinopharm's largest operating segment is pharmaceutical distribution, making up over 70% of its total revenue by the end of 2023. In 2018, Sinopharm acquired the largest Chinese medical device distributor, China National Scientific Instruments and Materials. Now, medical device distribution accounts for over 20% of Sinopharm's total revenue. Sinopharm's downstream customers range from hospitals and other health services institutions to end-customers.